Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 181

1.

[Experience and future prospect of hepatocellular carcinoma treatment by sorafenib].

Kaibori M, Ishizaki M, Matsui K.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(1):18-27. doi: 10.11405/nisshoshi.116.18. Japanese. No abstract available.

PMID:
30626850
2.

Validation of index-based IWATE criteria as an improved difficulty scoring system for laparoscopic liver resection.

Tanaka S, Kawaguchi Y, Kubo S, Kanazawa A, Takeda Y, Hirokawa F, Nitta H, Nakajima T, Kaizu T, Kaibori M, Kojima T, Otsuka Y, Fuks D, Hasegawa K, Kokudo N, Kaneko H, Gayet B, Wakabayashi G.

Surgery. 2018 Nov 13. pii: S0039-6060(18)30724-4. doi: 10.1016/j.surg.2018.10.012. [Epub ahead of print]

PMID:
30446171
3.

Hepatectomy in a case of hepatocellular carcinoma with constitutional indocyanine green excretory defect.

Nakatake R, Ishizaki M, Miyasaka C, Matsui K, Kaibori M.

Int J Surg Case Rep. 2018;53:231-234. doi: 10.1016/j.ijscr.2018.10.074. Epub 2018 Nov 1.

4.

Prognostic factors of hepatectomy in initially unresectable colorectal liver metastasis: Indication for conversion therapy.

Iida H, Kaibori M, Wada H, Hirokawa F, Nakai T, Kinoshita M, Hayashi M, Eguchi H, Kubo S.

Mol Clin Oncol. 2018 Nov;9(5):545-552. doi: 10.3892/mco.2018.1707. Epub 2018 Sep 3.

5.

Surgical Outcomes of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Korea-Japan Multicenter Study.

Kim DS, Kim BW, Hatano E, Hwang S, Hasegawa K, Kudo A, Ariizumi S, Kaibori M, Fukumoto T, Baba H, Kim SH, Kubo S, Kim JM, Ahn KS, Choi SB, Jeong CY, Shima Y, Nagano H, Yamasaki O, Yu HC, Han DH, Seo HI, Park IY, Yang KS, Yamamoto M, Wang HJ.

Ann Surg. 2018 Sep 13. doi: 10.1097/SLA.0000000000003014. [Epub ahead of print]

PMID:
30216223
6.

Resection for Primary Retroperitoneal Serous Adenocarcinoma and Liver Metastasis.

Nakatake R, Ishizaki M, Ishida M, Matsui K, Kawaguchi Y, Kaibori M.

Intern Med. 2018 Dec 1;57(23):3371-3375. doi: 10.2169/internalmedicine.0591-17. Epub 2018 Aug 10.

7.

Preoperative assessment of frailty predicts age-related events after hepatic resection: a prospective multicenter study.

Tanaka S, Ueno M, Iida H, Kaibori M, Nomi T, Hirokawa F, Ikoma H, Nakai T, Eguchi H, Kubo S.

J Hepatobiliary Pancreat Sci. 2018 Aug;25(8):377-387. doi: 10.1002/jhbp.568. Epub 2018 Jul 23.

PMID:
29949221
8.

Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.

Kaibori M, Yoshii K, Hasegawa K, Ogawa A, Kubo S, Tateishi R, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan.

Ann Surg. 2018 Mar 30. doi: 10.1097/SLA.0000000000002751. [Epub ahead of print]

PMID:
29608544
9.

Preoperative weight loss program involving a 20-day very low-calorie diet for obesity before laparoscopic gastrectomy for gastric cancer.

Inoue K, Yoshiuchi S, Yoshida M, Nakamura N, Nakajima S, Kitamura A, Mouri K, Michiura T, Mukaide H, Ozaki T, Miki H, Yanagimoto H, Satoi S, Kaibori M, Hamada M, Kimura Y, Kon M.

Asian J Endosc Surg. 2018 Mar 25. doi: 10.1111/ases.12479. [Epub ahead of print]

PMID:
29575594
10.

Reply to "Relative Survival Instead of Overall Survival Should be Used as Outcome When Analyzing the Effect of Age After Treatment of Hepatocellular Carcinoma".

Kaibori M, Yoshii K, Yokota I.

Ann Surg. 2018 Dec;268(6):e76-e77. doi: 10.1097/SLA.0000000000002704. No abstract available.

PMID:
29420317
11.

Ratio of mean platelet volume to platelet count is a potential surrogate marker predicting liver cirrhosis.

Iida H, Kaibori M, Matsui K, Ishizaki M, Kon M.

World J Hepatol. 2018 Jan 27;10(1):82-87. doi: 10.4254/wjh.v10.i1.82.

12.

Third-generation oncolytic herpes simplex virus inhibits the growth of liver tumors in mice.

Nakatake R, Kaibori M, Nakamura Y, Tanaka Y, Matushima H, Okumura T, Murakami T, Ino Y, Todo T, Kon M.

Cancer Sci. 2018 Mar;109(3):600-610. doi: 10.1111/cas.13492. Epub 2018 Feb 14.

13.

A sense oligonucleotide to inducible nitric oxide synthase mRNA increases the survival rate of rats in septic shock.

Okuyama T, Nakatake R, Kaibori M, Okumura T, Kon M, Nishizawa M.

Nitric Oxide. 2018 Jan 30;72:32-40. doi: 10.1016/j.niox.2017.11.003. Epub 2017 Nov 8.

PMID:
29128398
14.

Loss of skeletal muscle mass in patients with chronic liver disease is related to decrease in bone mineral density and exercise tolerance.

Hayashi F, Kaibori M, Sakaguchi T, Matsui K, Ishizaki M, Kwon AH, Iwasaka J, Kimura Y, Habu D.

Hepatol Res. 2018 Apr;48(5):345-354. doi: 10.1111/hepr.13000. Epub 2017 Dec 7.

PMID:
29115721
15.

Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey.

Kaibori M, Yoshii K, Yokota I, Hasegawa K, Nagashima F, Kubo S, Kon M, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan.

Ann Surg. 2017 Sep 15. doi: 10.1097/SLA.0000000000002526. [Epub ahead of print]

PMID:
28922205
16.

Combination therapies for primary hepatic neuroendocrine carcinoma: a case report.

Nakatake R, Ishizaki M, Matui K, Yanagimoto H, Inoue K, Kaibori M, Kawaguchi Y, Kon M.

Surg Case Rep. 2017 Sep 11;3(1):102. doi: 10.1186/s40792-017-0378-z.

17.

Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma.

Kaibori M, Kon M, Kitawaki T, Kawaura T, Hasegawa K, Kokudo N, Ariizumi S, Beppu T, Ishizu H, Kubo S, Kamiyama T, Takamura H, Kobayashi T, Kim DS, Wang HJ, Kim JM, Han DH, Park SJ, Kang KJ, Hwang S, Roh Y, You YK, Joh JW, Yamamoto M.

J Hepatobiliary Pancreat Sci. 2017 Nov;24(11):616-626. doi: 10.1002/jhbp.502. Epub 2017 Oct 19.

PMID:
28887834
18.

Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosome has antineoplastic effects for hepatocellular carcinoma.

Tsuda T, Kaibori M, Hishikawa H, Nakatake R, Okumura T, Ozeki E, Hara I, Morimoto Y, Yoshii K, Kon M.

PLoS One. 2017 Aug 31;12(8):e0183527. doi: 10.1371/journal.pone.0183527. eCollection 2017.

19.

ElentalĀ® amino acid component has protective effects on primary cultured hepatocytes and a rat model of acute liver injury.

Miki H, Tokuhara K, Oishi M, Tanaka Y, Nakatake R, Ueyama Y, Kaibori M, Nishizawa M, Okumura T, Kon M.

Nutr Res. 2017 Jun;42:71-84. doi: 10.1016/j.nutres.2017.04.010. Epub 2017 May 5.

PMID:
28633873
20.

Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.

Wada H, Eguchi H, Nagano H, Kubo S, Nakai T, Kaibori M, Hayashi M, Takemura S, Tanaka S, Nakata Y, Matsui K, Ishizaki M, Hirokawa F, Komeda K, Uchiyama K, Kon M, Doki Y, Mori M.

Surg Today. 2018 Jan;48(1):73-79. doi: 10.1007/s00595-017-1553-3. Epub 2017 Jun 8.

PMID:
28597349

Supplemental Content

Loading ...
Support Center